Site içinde arama yapın

Sophia Sanjay bir ses eklendi Health
2026-02-16 05:54:52 -

13 Strategic Shifts in the 2026 STD Diagnostic Market: Point-of-Care Molecular Testing, Multiplex Assays, and Digital Surveillance Integration
As of February 2026, the global diagnostic landscape is undergoing a structural realignment in response to rising infection rates and the demand for decentralized testing, with the Sexually Transmitted Diseases Diagnostic Market emerging as a focal point for molecular innovation. The transition from traditional laboratory-based culture methods to rapid Nucleic Acid Amplification Tests...

0 Yorumlar 0 hisse senetleri 240 Views 0 önizleme

Please log in to like, share and comment!
Akshay Gorde bir ses eklendi Health
2026-02-26 12:04:18 -

Molecular Diagnostic Market Growth, Analysis Industry Outlook & Region ForecastAnalysis By FMI
NEWARK, DE | The molecular diagnostics market stood at USD 17.1 billion in 2025 and is projected to expand to USD 18.5 billion in 2026 before climbing to USD 41.5 billion by 2036, reflecting a steady CAGR of 8.4% over the forecast period. Growth is increasingly propelled by regulatory shifts—particularly the FDA's finalized rule on Laboratory Developed Tests...

0 Yorumlar 0 hisse senetleri 133 Views 0 önizleme

Please log in to like, share and comment!
Sophia Sanjay bir ses eklendi Health
2026-02-16 06:14:06 -

Strategic Developments in the 2026 STDs Diagnostic Market: Molecular Multiplexing, POC Integration, and Public Health Surveillance
As of February 2026, the global diagnostic landscape is witnessing a structural transition in the management of infectious pathologies, with the Sexually Transmitted Diseases Diagnostic Market moving toward high-sensitivity molecular platforms and decentralized testing. The maturation of Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) has enabled clinicians to provide...

0 Yorumlar 0 hisse senetleri 200 Views 0 önizleme

Please log in to like, share and comment!